Global Sexually Transmitted Diseases Testing Market 2023-2029
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global sexually transmitted diseases testing market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the component, location of testing, technology, application, and region. The global market for sexually transmitted diseases testing can be segmented by component: consumables, instruments, software. The consumables segment was the largest contributor to the global sexually transmitted diseases testing market in 2022. Sexually transmitted diseases testing market is further segmented by location of testing: laboratory testing, point of care (PoC) testing. According to the research, the laboratory testing segment had the largest share in the global sexually transmitted diseases testing market. Based on technology, the sexually transmitted diseases testing market is segmented into: immunoassays, polymerase chain reaction (PCR), others. The immunoassays segment held the largest revenue share in 2022. On the basis of application, the sexually transmitted diseases testing market also can be divided into: chlamydia, genital herpes, gonorrhea, hepatitis B, HIV and AIDS, human papillomavirus (HPV), syphilis, others. Sexually transmitted diseases testing market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.
Market Segmentation
By component: consumables, instruments, software
By location of testing: laboratory testing, point of care (PoC) testing
By technology: immunoassays, polymerase chain reaction (PCR), others
By application: chlamydia, genital herpes, gonorrhea, hepatitis B, HIV and AIDS, human papillomavirus (HPV), syphilis, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report also provides analysis of the key companies of the industry and their detailed company profiles including Abbott Laboratories, AbbVie Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, bioMerieux SA, Bio-rad Laboratories, Inc., Danaher Corporation, DiaSorin S.p.A., Esco Micro Pte. Ltd., F. Hoffmann-La Roche AG, Gen-Probe Incorporated (Hologic, Inc.), MedMira Holding AG, Meridian Bioscience Inc., OraSure Technologies, Inc., Qiagen N.V., QuantuMDx Group Ltd., QuidelOrtho Corporation, Seegene, Inc., Sekisui Medical Co., Ltd., Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Trinity Biotech Plc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
To analyze and forecast the market size of the global sexually transmitted diseases testing market.
To classify and forecast the global sexually transmitted diseases testing market based on component, location of testing, technology, application, region.
To identify drivers and challenges for the global sexually transmitted diseases testing market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global sexually transmitted diseases testing market.
To identify and analyze the profile of leading players operating in the global sexually transmitted diseases testing market.
Why Choose This Report
Gain a reliable outlook of the global sexually transmitted diseases testing market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY COMPONENT
Consumables
Instruments
Software
PART 6. MARKET BREAKDOWN BY LOCATION OF TESTING
Laboratory testing
Point of care (PoC) testing
PART 7. MARKET BREAKDOWN BY TECHNOLOGY
Immunoassays
Polymerase chain reaction (PCR)
Others
PART 8. MARKET BREAKDOWN BY APPLICATION
Chlamydia
Genital herpes
Gonorrhea
Hepatitis B
HIV and AIDS
Human papillomavirus (HPV)
Syphilis
Others
PART 9. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America
PART 10. KEY COMPANIES
Abbott Laboratories
AbbVie Inc.
Agilent Technologies, Inc.
Becton, Dickinson and Company
bioMerieux SA
Bio-rad Laboratories, Inc.
Danaher Corporation
DiaSorin S.p.A.
Esco Micro Pte. Ltd.
F. Hoffmann-La Roche AG
Gen-Probe Incorporated (Hologic, Inc.)
MedMira Holding AG
Meridian Bioscience Inc.
OraSure Technologies, Inc.
Qiagen N.V.
QuantuMDx Group Ltd.
QuidelOrtho Corporation
Seegene, Inc.
Sekisui Medical Co., Ltd.
Siemens Healthineers AG
Thermo Fisher Scientific, Inc.
Trinity Biotech Plc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
USD 7500 View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
USD 2450 View Report2024 Europe Sexually Transmitted Disease STD Market
2024 Europe Sexually-Transmitted Disease (STD) Market: Shares and Segment Forecasts--AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, Trichomonas VaginalisThis new report from contains analysis of
USD 7500 View Report2024 Global Sexually Transmitted Disease STD Market
2024 Global Sexually-Transmitted Disease (STD) Market (US, Europe, Japan): Shares and Segment Forecasts--AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, Trichomonas VaginalisThis new report from
USD 9500 View ReportFill The Form For Sample Request